COLLEYVILLE, TX--(Marketwire - April 29, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has been featured in The Wall Street Transcript's recent Software Issue. The interview features company CEO David Lee. Highlights from the interview include:

--  Overview of digiMedical's proprietary Microsoft-based, HIPAA compliant
    digital prescription technology
--  digiMedical digital prescription technology meets Drug Enforcement
    Administration (DEA) regulations to aide in the control of Schedule II
    prescription drug abuse
--  Overview of digiMedical's five Company-owned pharmacies in Florida and
--  The evolvement of the pharmacy industry and the need for digital
    prescription technology, reducing human error, injury to patients and
    fraudulent prescriptions
--  digiReAuth, the Company's proprietary prescription re-authorization
    technology allowing patients to refill prescriptions through digiMedical's
    call center
--  2008 growth and beyond, including the continued acquisition of
    independent pharmacy chains and possible expansion into Latin American
--  Expansion of current physician-base, gaining hundreds of patients with
    each new doctor and simultaneously realizing notable increases in
    prescription reauthorizations through digiMedical's call center
--  Current efforts to make the digiRX line Microsoft certified, making it
    a more widely recognized technology
--  Recent additions to the board of directors with experience that will
    help the Company transition off of the OTC to become a fully-reporting
    OTCBB listed company

The interview is available at For help viewing the article, please contact

Corporate Fact Sheet and Email Updates

To receive a copy of the Company's corporate fact sheet, or future corporate updates via email, please send an email to

About digiMedical Solutions, Inc.™

digiMedical Solutions, Inc.™ ( is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates five (5) pharmacies located in Texas and Florida. digiMedical Solutions'™ unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029